How does Sorabenz 200mg Tablet work?

Sorabenz 200mg Tablet works by blocking the action of a protein that signals the cancer cells to multiply. It helps to slow down the growth of cancer cells.

What are the side effects of Sorabenz 200mg Tablet?

Some common side effects of Sorabenz 200mg Tablet are nausea, irregular heartbeat, seizures, pale skin, abdominal pain, bleeding, diarrhea, fatigue, etc.

Can I take Sorabenz 200mg Tablet during pregnancy?

Sorabenz 200mg is not recommended for pregnant women.

Can I drive after taking the Sorabenz tablet?

Sorabenz 200mg Tablet may decrease your ability to drive or affect your vision. Do not drive if any symptoms occur.

Buy Sorabenz 200mg Tablet Online: Price, 62% Discount, Uses, and Side Effects

Description

Sorabenz 200mg Tablet is an anticancer medicine with Sorafenib as an active ingredient. This tablet belongs to a group of medications called tyrosine kinase inhibitors.

It is prescribed to treat certain types of cancer, including liver cancer, kidney cancer, and thyroid cancer. Sorafenib is a kinase inhibitor that helps to stop the growth of cancerous cells by blocking the action of an abnormal protein.

It should be taken in dose and duration as advice by the doctor. Don't take more than the recommended dose.

Uses

Thyroid cancer
Kidney cancer
Liver cancer

Side Effects

Like any other anticancer medicine, Sorabenz 200mg Tablet also shows some side effects, which vary from one person to another according to various health factors. Most of them are mild, and some are serious enough to need immediate medical attention.
Some common side effects include:

Nausea
Fatigue
Loss of appetite
Diarrhea
Abdominal pain
Hair loss
Weight loss
Rash
Painful blisters on hands and feet

Seek medical attention in case of any unusual or severe side effects immediately.

How To Use

The dosage and duration of the Sorabenz 200mg Tablet are decided by the doctor based on the stage & type of cancer and other health factors. Take this tablet on an empty stomach for better results. Before starting this medicine, please inform your doctor about your medical history.
If you experience any signs and symptoms while eating this medication that are not manageable, do not ignore those symptoms because they may lead to a higher risk.

How It Works

Sorabenz 200mg Tablet is an anticancer medicine. This tablet belongs to a group of medications called tyrosine kinase inhibitors works by blocking the action of the abnormal protein that is responsible for the uncontrolled growth of cancerous cells.

It effectively slows down the progression of cancer by controlling the multiplication of cancer cells.

Safety Advice

Alcohol

Avoid the consumption of alcohol while taking Sorabenz 200mg Tablet, as alcohol can decrease the effectiveness of the medicine as well as worsen the symptoms.

Pregnancy

Do not take Sorabenz 200mg Tablet without consulting the doctor in case of pregnancy, as it can be unsafe to take it during this period.

Breast Feeding

Breastfeeding women should discuss the potential risks and benefits of the Sorabenz 200mg Tablet with their healthcare provider before starting treatment.

Driving

Sorabenz 200mg Tablet is usually consider safe in case of driving as it does not affect your ability to drive.

Kidney

Sorabenz 200mg Tablet is safe for use in kidney disease if prescribed by the doctor. No dosage adjustment is necessary for this Tablet.

Liver

Share your medical history with the doctor before starting the Sorabenz 200mg Tablet. Do not take it without consulting a doctor if you have any liver related issue.

FAQs

Sorabenz 200mg Tablet is used to treat a certain type of cancer, such as liver cancer, kidney cancer, and thyroid cancer, by stopping the growth of cancerous cells.

References

Zhu, Y. J., Zheng, B., Wang, H. Y., & Chen, L. (2017). New knowledge of the mechanisms of sorafenib resistance in liver cancer. Acta Pharmacologica Sinica, 38(5), 614-622. https://pubmed.ncbi.nlm.nih.gov/28344323/
Woo, H. Y., & Heo, J. (2012). Sorafenib in liver cancer. Expert opinion on pharmacotherapy, 13(7), 1059-1067.https://pubmed.ncbi.nlm.nih.gov/22519770/
Kane, R. C., Farrell, A. T., Saber, H., Tang, S., Williams, G., Jee, J. M., ... & Pazdur, R. (2006). Sorafenib for the treatment of advanced renal cell carcinoma. Clinical cancer research, 12(24), 7271-7278. https://pubmed.ncbi.nlm.nih.gov/17189398/
Zhu, Y. J., Zheng, B., Wang, H. Y., & Chen, L. (2017). New knowledge of the mechanisms of sorafenib resistance in liver cancer. Acta Pharmacologica Sinica, 38(5), 614-622. https://pubmed.ncbi.nlm.nih.gov/28344323/
Thomas, L., Lai, S. Y., Dong, W., Feng, L., Dadu, R., Regone, R. M., & Cabanillas, M. E. (2014). Sorafenib in metastatic thyroid cancer: a systematic review. The oncologist, 19(3), 251-258. https://pubmed.ncbi.nlm.nih.gov/24563075/
Fallahi, P., Ferrari, S. M., Santini, F., Corrado, A., Materazzi, G., Ulisse, S., ... & Antonelli, A. (2013). Sorafenib and thyroid cancer. BioDrugs, 27(6), 615-628. https://pubmed.ncbi.nlm.nih.gov/23818056/

Sorabenz 200mg Tablet

About The Product